News
IDIBELL involves citizens with the survey «Health in times of confinement due to coronavirus»
The epidemic caused by the new coronavirus has negatively impacted millions of people around the world. Confinement has forced citizens to drastically change the way of relating, working and understanding everyday reality. To evaluate various parameters related to health and habits before and after confinement, the Psychiatry research group of the Bellvitge Biomedical Research Institute […]
Ribosome biogenesis senses nucleotide levels to preserve DNA integrity
When nucleotide levels drop, a common step during initiation of aggressive cancers, ribosomes biogenesis detects it and prevent DNA replication, as this could lead to genome damage.
Check our open opportunities, meet us at our MSCA-IF bootcamp
IDIBELL is seeking postdoctoral researchers interested in appling to Marie Skłodowska-Curie Actions grant (MSCA-IF). Join us!
More than € 60,000 to fight COVID-19
A recent donation from the Coordinating Association “Viladecans against Cancer” raises the scoreboard of the #BellvitgeInvestiga crowdfunding initiative to more than € 60,000.
We will use these funds to accelerate research projects against COVID-19.
The premiere of the documentary “Bellvitge, a hospital transformed by Covid-19”
The documentary narrates, with the voice of health and research personnel, the transformation of IDIBELL and the Bellvitge University Hospital to face the pandemic, from the doubling of beds for critical patients, to the launch of multiple research projects for better understanding of the new coronavirus.
Blood vessels development depends on the maturation state of the pericytes that enclose them
Many diseases are associated with a dysregulation in blood vessel formation. Now an IDIBELL group has defined a model of pericyte maturation during vessel formation and has developed tools to study them, which could help to decipher their contribution to these diseases.
Artificial intelligence applied to clinical oncology
ModGraProDep is an innovative system that, through artificial intelligence and the design of probabilistic models, improves the prediction of survival indicators in breast cancer patients. This study, published in the journal Artificial Intelligence in Medicine, has been led by Ramon Clèries, professor at the Department of Clinical Sciences of the Faculty of Medicine and Health […]
The P-CMR[C] launches its website
The Program for advancing the Clinical Translation of Regenerative Medicine of Catalonia (P-CMR[C]), which aims to group research on stem cells in Catalonia, now has its own space in internet.
Laura Valle has received the CIBERONC 2020 award
The researcher Laura Valle has been awarded the CIBERONC 2020 award at the IV Annual CIBERONC Meeting held at the National School of Health of the Carlos III Health Institute in Madrid. Laura Valle, a principal investigator in the IDIBELL hereditary cancer group and CIBERONC researcher, has received the Best CIBERONC 2020 Researcher Award. The […]